The Company's aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma (BCC) of the skin using Dissolvable Doxorubicin-containing Microneedle Arrays ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

CorMedix is a bio-pharmaceutical company that produces DefenCath, an antimicrobial catheter lock solution containing ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer ...

A rundown of recent Trump administration vaccine policy changes Doctors’ groups have expressed alarm at the moves made by Health Secretary Robert F. Kennedy Jr. and his appointees.

Owing to substantial associated toxicities, oral estrogens were abandoned as treatments for prostate carcinoma. Parenteral estrogen administration may obviate the toxicities.

This story was originally published by ProPublica. The Trump administration has launched a major reorganization of the U.S. fight against drug traffickers and other transnational criminal groups ...

Some have proposed philanthropy or the private sector could make up for NIH funding cuts. But they can’t come close.

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 Published Jun 25, 2025 8:00am EDT ...

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 ...